Share Email Print
cover

Proceedings Paper

Early panretinal photocoagulation for the treatment of ischemic central retinal vein occlusion
Author(s): Zikui Yu; Naizhen He
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Objective: To evaluate the safety and efficacy of treating ischemic central retinal vein occlusion (CRVO) with early panretinal photocoagulation (PRP). Methods: 24 eyes of 24 cases suffered from ischemic CRVO with history shorter than 3 months were included in this study. PRP treatments were completed through 3 to 5 times of laser therapy with total laser burns of 1000 to 2000 (mean 1505±384). Patients were followed up 3 months to 2 years, mean 18.4±8.0 months. The neovascularization regression and visual acuity were compared before and after PRP, also the long-term complications were observed. Results: 3 eyes of iris neovascularization (INV) regressed after PRP and there was no significant difference in visual acuity between prelaser and postlaser. No neovascular glaucoma (NVG) occurred and 2 eyes occurred vitreous hemorrhage during the follow up period. Conclusions: Early panretinal photocoagulation is safe and efficacious in preventing and reducing complications of ischemic CRVO. It can save valuable treatment time for some patients.

Paper Details

Date Published: 11 September 2006
PDF: 4 pages
Proc. SPIE 5967, 2004 Shanghai International Conference on Laser Medicine and Surgery, 59671M (11 September 2006); doi: 10.1117/12.639341
Show Author Affiliations
Zikui Yu, Renji Hospital/Shanghai Second Medical Univ. (China)
Naizhen He, Renji Hospital/Shanghai Second Medical Univ. (China)


Published in SPIE Proceedings Vol. 5967:
2004 Shanghai International Conference on Laser Medicine and Surgery
Jing Zhu, Editor(s)

© SPIE. Terms of Use
Back to Top